Gene Query: MXD1

Dataset Description Geneva Score
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 103.45
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 96.22
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 87.7
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 81.21
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 74.34
Effect of Influenza virus infection on lncRNA expression in A549 cells 66.22
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 64.94
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 60.7
Gene expression in PANC1 cells treated with Rakicidin 56.21
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 53.72
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 52.65
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 51.1
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 50.39
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 49.97
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 43.08
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 41.54
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 41.25
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 41.07
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 40.85
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 40.16
The regulartory role of ZCCHC24 in splicing machinery 36.08
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 34.89
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 33.51
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 33.11
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 32.58
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 32.26
Genome-wide analysis of Dengue virus 2 infected cells 31.97
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 31.51
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 30.81
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 30.7
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 30.47
Transcriptome analysis in Neobractatin treated cells 29.92
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 28.91
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 28.69
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 28.31
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 28.15
Characterization of the Merkel cell carcinoma miRNome 27.82
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 27.51
R430: A potent inbibitor of DNA and RNA viruses 26.65
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 26.32
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 26.27
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 25.73
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 25.63
MAIT cell RNA sequencing 24.89
U2AF1 mutations alter splice site recognition in hematological malignancies 24.89
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 24.21
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 24.03
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 24.03
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 23.49
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 23.47
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 22.66
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 22.51
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 22.18
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 22.08
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 21.89
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 21.66
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 21.29
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 21.26
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 21.17
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 21.16
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 20.82
Effect of BB608 on Gene Expression in HNSCC Cell Line 20.75
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 20.68
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 20.49
Glioblastoma stem cells infected by ZIKA virus 20.42
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 20.4
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 20.36
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 20.36
CircRNAome diversity in human mature B-cells, T-cells and monocytes 20.08
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 19.9
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 19.78
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 19.72
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 19.44
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 19.27
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 19.27
Gene expression alterations of pancreatic intraepithlial neoplasia 19.18
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 18.92
circRNA profile in hypopharyngeal cancer 18.9
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 18.79
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 18.73
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 18.69
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 18.69
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 18.36
MEIS1 regulates hematopoiesis in hPSCs 18.34
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 18.34
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 18.34
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 18.2
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 18.2
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 18.19
BAF controls genome accessibility 18.11
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 17.95
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 17.75
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 17.75
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 17.7
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 17.7
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 17.4
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 17.37
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 17.34
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 17.21
RNAseq analysis of ESRP regulated splicing events in prostate cancer 16.95
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 16.94
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 16.76
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 16.65
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 16.45
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 16.39
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 15.96
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 15.93
Genome wide expression change by RNF168 knocking down in NEC cells 15.73
RNA-sequencing of human tendon after injury 15.72
Total RNA sequencing of APC mutant and wt colonic organoids 15.69
Transcriptomic and gene ontology profiling of the human corneal cell types 15.48
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 15.48
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 15.44
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 15.43
Macrophage Ad5f35 M2 Challenge 15.3
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 15.3
ZIKV infection of monocytes activates inflammasome pathways 15.27
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 15.25
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 15.13
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 15.13
MeRIP-seq for heat shock in B-cell lymphoma cells 14.92
Total RNA sequencing of WT intestinal orgaonids. 14.86
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 14.78
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 14.72
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 14.72
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 14.64
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 14.54
Effect of nuclear IL-33 on gene expression 14.53
BASP1 modifies the Tamoxifen response 14.43
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 14.4
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 14.26
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 14.26
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 14.21
A map of gene expression in neutrophil-like cell lines 14.19
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 14.16
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 14.03
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 14.03
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 13.97
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 13.9
Human HAP1 cells before and after nutrient deprivation 13.9
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 13.84
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 13.84
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 13.77
A Unique Epigenomic Landscape Defines Human Erythropoiesis 13.55
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 13.55
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 13.48
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 13.48
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 13.46
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 13.33
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 13.29
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 13.25
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 13.17
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 13.16
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 13.16
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 13.15
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 13.13
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 13.07
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 13.07
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 13.07
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 13.07
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 13.04
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 12.94
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 12.9
Gene expression analysis of dengue-infected cells 12.86
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 12.83
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 12.8
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 12.62
Human T-cell lymphoblastic lymphoma samples and control thymuses 12.62
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 12.6
Short and Long RNA sequencing of human mature erythrocytes 12.58
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 12.38
Regulation of hypoxia-inducible factor activity by ZMYND8 12.34
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 12.29
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 12.29
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 12.2
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 12.19
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 12.16
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 12.16
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 12.1
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 12.07
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 12.07
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 11.95
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 11.87
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 11.83
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 11.83
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 11.81
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 11.79
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 11.73
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 11.68
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 11.63
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 11.63
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 11.54
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 11.5
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 11.48
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 11.41
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 11.39
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 11.32
Role of cervicovaginal microbiota in genital inflammation 11.23
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 11.2
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 11.17
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 11.16
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 11.13
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 11.03
Human neutrophil genome during PMA- and E. coli encounter-induced activation 11.01
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 11.01
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 10.98
Peptidomimetic blockade of MYB in acute myeloid leukemia 10.98
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 10.86
Tracking of dCas9-methyltransferase footprints 10.86
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 10.8
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 10.79
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 10.79
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 10.78
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 10.75
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 10.68
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 10.64
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 10.55
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 10.52
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 10.48
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 10.43
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 10.39
LncRNA expression profiling of ischemic stroke patients 10.38
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 10.25
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 10.11
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 10.09
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 10.08
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 10.02
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 10.01
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 10.0
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 9.93
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 9.89
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 9.83
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 9.82
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 9.78
Transcriptomes of oxLDL exposed trained monocytes 9.75
oxLDL exposed trained monocytes 9.75
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 9.73
Transcriptional profiling of LS1034 cells treated with tepoxalin 9.64
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 9.57
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 9.5
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 9.49
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 9.47
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 9.43
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 9.42
Transcriptional dependencies in diffuse intrinsic pontine glioma 9.39
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 9.32
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 9.31
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 9.26
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 9.14
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 9.14
Hepatitis C virus functionally sequesters miR-122 9.12
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 9.12
p63 controls the enhancer landscape during keratinocyte differentiation 9.09
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 9.01
Transcriptional profile in human S. haematobium infection 8.98
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 8.94
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 8.94
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 8.94
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 8.93
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 8.93
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 8.78
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 8.72
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 8.71
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 8.6
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 8.51
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 8.3
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 8.3
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 8.3
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 8.25
WRN knockout effects upon gene expression in SW48 and OVK18 8.25
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 8.17
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 8.14
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 8.14
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 8.09
The transcriptome of Kawasaki Disease arteritis 8.01
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 7.95
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 7.93
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 7.89
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 7.85
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 7.8
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.71
RNA Sequencing of three pairs of gastric cancer 7.57
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 7.48
Direct Isolation and Characterization of Human Nephron Progenitors. 7.46
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 7.37
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 7.32
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 7.32
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 7.29
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 7.26
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 7.26
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 7.24
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 7.24
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 7.23
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 7.2
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 7.18
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 7.14
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 7.12
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 7.12
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 7.12
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 7.09
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 7.09
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 7.04
Aging-associated patterns in the expression of human endogenous retroviruses 6.85
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 6.82
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 6.75
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 6.68
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 6.66
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 6.59
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 6.57
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 6.47
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 6.46
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 6.45
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 6.38
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.37
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.37
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 6.24
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 6.2
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 6.17
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 6.14
SLIGRL-induced gene expression changes in NHEK cells 6.08
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 5.96
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 5.95
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.9
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 5.87
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 5.86
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 5.86
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.85
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 5.75
Frailty in middle age is associated with race-specific changes to the transcriptome. 5.7
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 5.55
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.52
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 5.5
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 5.49
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 5.45
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.44
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 5.38
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 5.38
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 5.38
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 5.34
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 5.31
Integrin signaling regulates YAP/TAZ to control skin homeostasis 5.29
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 5.28
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 5.28
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 5.27
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 5.27
Targeting MTHFD2 in Acute Myeloid Leukemia 5.26
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 5.24
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 5.23
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 5.17
RNA-seq analysis of the human fetal kidney. 5.13
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 5.13
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 5.11
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 5.11
Intrahepatic MAIT cell gene expression revealed by RNA-seq 5.07
Dysregulated immune system networks in war veterans with PTSD 5.03
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 5.01
Gene expression changes due to PARP knockdown in human cells 4.91
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 4.9
RNA-seq data 4.79
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 4.71
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 4.68
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.65
Transcriptional effect of ETV1 knockdown in melanoma cells 4.62
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 4.59
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.54
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 4.53
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 4.47
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 4.47
Characterization of human ILC2 subsets 4.39
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 4.32
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 4.29
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.26
Universal alternative splicing of noncoding exons 4.18
Transcriptome analysis reveals differential splicing events in IPF lung tissue 4.17
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 4.12
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 4.09
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 4.08
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 4.08
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.08
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 4.03
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 3.82
RNA seq analysis of human Fetal and adult derived Enterospheres 3.77
Dermal endothelial cells of type 2 diabetic patients 3.76
Generation of KRAS signatures using immortalized isogenic lung cells. 3.74
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 3.68
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 3.67
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 3.65
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 3.58
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 3.53
An optimization system for isolating and sequencing of single human colon cancer cells 3.52
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 3.52
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 3.52
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.48
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 3.45
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 3.45
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.44
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 3.33
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 3.32
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 3.32
MCF-7 as a model for functional analysis of breast cancer risk variants 3.31
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.29
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 3.27
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 3.27
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 3.24
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 3.23
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 3.23
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 3.19
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 3.14
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 3.13
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 3.12
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 3.11
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 3.04
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 3.02
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 2.99
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.93
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.89
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 2.86
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 2.86
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.83
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 2.82
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 2.72
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.7
RNAseq of T-ALL upon long non coding rna purturbation 2.7
RNA-sequencing 2.68
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 2.65
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 2.63
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 2.61
Macrophage Ad5f35 PhenoMap 2.59
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 2.52
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 2.51
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 2.5
Common inflammatory pathways between NEC and Crohn's disease 2.47
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.39
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.26
Expression analysis of the TAF1 syndrome 2.2
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.17
RNA-Seq and expression data from human adipose tissue 2.17
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 2.17
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 2.1
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 2.1
Gene expression analysis of human adenomas. 2.08
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 2.08
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.04
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 2.01
Transcriptome analysis of peripheral blood monocytes 1.96
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.95
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 1.91
Expression profiling of converted and control dermal BJ fibroblasts 1.91
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.88
Evaluating pre-clinical models for studying NASH driven HCC. 1.77
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 1.7
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.65
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.64
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 1.64
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.6
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 1.56
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 1.56
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.54
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.54
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.54
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 1.5
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.49
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.47
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 1.43
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 1.43
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 1.34
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 1.33
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.33
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.24
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 1.13
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 1.13
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 1.08
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.07
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.98
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.95
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.93
RNA-seq of CD33 KO and control HSPCs 0.88
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.77
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.67
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.55
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.55
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 0.55
iPSC derived motor neuron cultures from C9ORF72 carriers 0.55
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.49
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.48
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 0.44
Trascriptome of thyroid cancer-induced macrophages 0.42
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.41
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.39
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 0.37
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.28
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.28
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.26
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.26
Gene expression profile of human placenta from T. Cruzi infected mothers 0.25
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.22
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.06
Specific molecular signatures underlie response to decitabine in CMML 0.06
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.02
Transcriptomic analysis of human macrophages in 3D 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation